Evidence map›Paper›PMID 42159831›Full record

ArticleCEN case reports2026

Severe mesangiolysis with prominent microaneurysm formation following total body irradiation conditioning for bone marrow transplantation.

Yosuke Nakagawa, Masahiro Koizumi, Norisuke Shimamura, Naoto Hamano, Go Ogura, Takehiko Wada, Makoto Onizuka, Hirotaka Komaba

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosuke NakagawaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.
Masahiro KoizumiDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan. koiz0907@gmail.com.ORCID 0000-0002-5830-5785
Norisuke ShimamuraDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.
Naoto HamanoDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.
Go OguraDepartment of Pathology, Tokai University School of Medicine, Isehara, Japan.
Takehiko WadaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.
Makoto OnizukaDepartment of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan.
Hirotaka KomabaDivision of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, 259-1193, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients who undergo hematopoietic stem cell transplantation (HSCT) face a high risk of acute kidney injury (AKI), which significantly increases the likelihood of developing chronic kidney disease (CKD). Proteinuria is also frequently observed after HSCT and is associated with an increased risk of CKD progression. Thrombotic microangiopathy (TMA), stemming from endothelial injury caused by factors such as total body irradiation (TBI), calcineurin inhibitors, tyrosine kinase inhibitors, and graft-versus-host disease, is a major contributor to both AKI and CKD. We report a case of a woman in her early thirties who developed progressive kidney dysfunction and subnephrotic-range proteinuria three months after HSCT. Kidney biopsy findings included marked mesangiolysis, endothelial cell detachment, subendothelial expansion, and diffuse segmental capillary microaneurysms, which are highly suggestive of TMA due to TBI administered as part of the myeloablative conditioning regimen prior to HSCT. She underwent conservative management for chronic kidney disease, but her kidney function progressively declined. In patients presenting with a progressive decline in kidney function following HSCT, TMA should be included in the differential diagnosis. A kidney biopsy is valuable for determining the underlying cause of HSCT-associated TMA, as treatment strategies vary depending on the etiology. Prominent mesangiolysis with capillary microaneurysms, as observed in this case and the previously reported irradiated patients, may serve as a distinctive histological marker of radiation nephropathy.

Indexed as

Acute Kidney InjuryAneurysmBone Marrow TransplantationHematopoietic Stem Cell TransplantationThrombotic MicroangiopathiesTransplantation ConditioningWhole-Body IrradiationAdultBiopsyFemaleHumansKidneyProteinuriaRenal Insufficiency, ChronicHematopoietic stem cell transplantationMesangiolysisMicroaneurysmRadiation nephropathyThrombotic microangiopathy

Identifiers

PMID42159831
PMCPMC13190939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.